Skip to main content
The Egyptian Heart Journal
Fig. 3 | The Egyptian Heart Journal

Fig. 3

From: Telmisartan versus EnalapRil In heart failure with redUced ejection fraction patients with Moderately impaired kidney Functions; randomized controlled trial: “TRIUMF trial”

Fig. 3

A Scores of 6MWT for the 2 groups at baseline and by the end of the study with demonstration of the within-group p value. B Daily requirements of the standardized loop diuretics dose from baseline to the end of the study demonstrating changes in dose requirements and the p values of within-group differences between baseline-to-6 months and 3-to-6 months

Back to article page